Hedge Fund - Propel Bio Management

Tscan Therapeutics Inc. (TCRX) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2024 - Q1 (2024-03-31) $16,571,884 9.64% 2,087,139 $
2 2023 - Q4 (2023-12-31) $12,168,020 10.08% 2,087,139 $4.58

The displayed share prices are average quarterly stock market prices.